Highly selective electrochemical sensor for new generation targeted-anticancer drug Ibrutinib using newly synthesized nanomaterial GO-NH-B(OH)2@AgNPs modified glassy carbon electrode

Abstract

Ibrutinib (IBR) is a small molecule new generation smart anti-cancer drug that is Bruton's tyrosine kinase (BTK) inhibitor. In this study, the sensitive and selective electrochemical sensor based on a modification of a glassy carbon electrode with a new GO-NH-B(OH)2 (graphene oxide boramidic acid) nanoparticles and Ag nanoparticles (AgNPs) is proposed for IBR determination. GO-NH-B(OH)2@AgNPs/GCE was characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), electrochemical impedance spectroscopy (EIS), and cyclic voltammetry (CV). The performance of the electrode was evaluated with the parameters of electrode surface area (A), heterogeneous rate constant (ket), standard exchange current density (I0). The electrochemical determination of IBR in 0.1 M HNO3 solution was investigated at the surface of GO-NH-B(OH)2@AgNPs/GCE. Under optimized square wave voltammetric (SWV) conditions, peaks current at GO-NH-B(OH)2@AgNPs/GCE showed good linearity with the concentration of IBR in the operating range of 0.025–1.00 μg mL−1 (5.7 × 10−8 – 2.3 × 10−6 M) with a detection limit (LOD) of 0.006 μg mL−1 (1.36 × 10−8 M). Besides its high stability and reproducibility, the response of IBR at GO-NH-B(OH)2@AgNPs/GCE was not influenced by the presence of dopamine, uric acid, and ascorbic acid. The sensor has successfully caught IBR in pharmaceutical and human urine samples.